Lonza expands Advanced Synthesis to accelerate ADC and bioconjugate development, integrating GlycoConnect, HydraSpace, dual-payload technology, and scalable CDMO services.
GSK has secured European Commission approval for Exdensur (depemokimab), a twice-yearly treatment for severe asthma and chronic rhinosinusitis with nasal polyps, offering sustained control for patients with uncontrolled type 2 inflammation.
Johnson & Johnson has secured FDA approval for a monthly dosing schedule of RYBREVANT FASPRO, marking a major step forward in first-line treatment for EGFR-mutated advanced non-small cell lung cancer.
Novartis announces sale of 70.68% stake in Novartis India for Rs 1,446 crore, with an offer to buy an additional 26% from public shareholders, marking a major strategic shift.
.png "Merck & Mayo Clinic Unite to Transform Drug Development")
Merck and Mayo Clinic have joined forces in a major AI-driven research deal aimed at reshaping drug discovery. The collaboration blends advanced analytics, genomic data, and clinical expertise to speed up new therapy development.
Dr Reddy’s is set to launch a semaglutide generic in India on Day 1 of patent expiry, offering both injectable and oral forms at significantly lower prices for diabetes and obesity patients.
Samsung Health partners with PharmEasy & Tata 1mg to launch ‘Find Care’ feature, offering seamless access to healthcare services like tests, doctor consultations, and medicine orders.
Zydus Lifesciences launches Anyra, India’s first homegrown Aflibercept 2 mg biosimilar, offering affordable treatment for AMD, DR, DME, RVO, and mCNV, boosting access to advanced retinal care nationwide.
Novartis reported positive Phase III RemIND trial results for remibrutinib in chronic inducible urticaria, showing higher complete response rates than placebo and moving closer to the first targeted therapy for CIndU.
GSK plc has reported strong real-world results for its RSV vaccine, showing major reductions in RSV-related hospitalizations and serious complications in adults aged 60 and older at RSVVW’26 in Rome.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")